Learn More
Medchemexpress LLC Purmorphamine | 483367-10-8 | C31H32N6O2 | 100 MG

Supplier: Medchemexpress LLC HY15108100MG
Purmorphamine is a potent smoothened/Smo receptor agonist with an EC50 of 1 μM and an IC50 of 1.5 μM for Smoothened. It is intended for research use only and not for human or animal therapeutic use. This compound promotes osteoblast differentiation and up-regulates key markers of the osteoblast phenotype, demonstrating its utility in studying bone development and related cellular processes.
- Acts as a smoothened/Smo receptor agonist
- Induces osteoblast differentiation
- Up-regulates alkaline phosphatase activity and RUNX-2 expression
- Up-regulates osteocalcin at specific doses
- Induces STAT3 phosphorylation
- Promotes bone-like nodule formation in human bone marrow mesenchymal cells
- Significantly decreases cell numbers in combination with sirolimus
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.